Dexcom announces direct-to-watch feature for G7 CGM
Mar 5, 2024 · The ONE+ system, featuring a sensor, reader, smartphone, smartwatch and applicator. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) announced today that it introduced a direct-to-Apple-Watch feature for its G7 continuous glucose monitor (CGM) users. The company plans a phased launch for all G7 iOS users everywhere by the end of the second quarter of this year.
Insulet data shows Omnipod 5's superiority to regular pump therapy
Mar 8, 2024 · The Omnipod 5 with the Abbott FreeStyle Libre 2 Plus. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today announced positive results from a clinical trial pitting its Omnipod 5 against non-automated insulin therapy. Acton, Massachusetts-based Insulet conducted its first randomized controlled trial showing improved glycemic and patient-reported outcomes in type 1 diabetes with the Omnipod 5 ...
Insulet fully launches Omnipod 5 with Dexcom G7 in the U.S.
Jun 20, 2024 · The Omnipod 5 with the Dexcom G7 CGM. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it began a full U.S. launch of Omnipod 5 with the Dexcom G7 continuous glucose monitor (CGM). The company also announced a series of launches and updates, including a limited release of the Omnipod 5 App for iPhone.
Know Labs unveils wearable, non-invasive CGM set to go to FDA
Feb 27, 2024 · A rendering of the KnowU non-invasive glucose monitor. [Image courtesy of Know Labs] Know Labs (NYSE:KNW) today unveiled KnowU, its wearable, non-invasive continuous glucose monitor (CGM) system. Seattle-based Know Labs first announced its initial prototype last June.It says KnowU is the result of an accelerated development process over …
Insulet progresses on Omnipod 5, FreeStyle Libre 2 integration
Jun 22, 2023 · The Insulet Omnipod 5 [Photo courtesy of Insulet] Insulet (Nasdaq:PODD) today announced a duo of updates related to its Omnipod 5 system that includes a significant integration development. Acton, Massachusetts-based Insulet plans to discuss a range of developments related to its product line in the coming days at the American Diabetes Association (ADA) 83 rd Scientific Sessions in San Diego.
The 9 largest diabetes technology companies in the world
Aug 21, 2024 · Technologies from Abbott, Dexcom, Medtronic and Insulet. These companies are the four largest diabetes technology companies in the world. [Images courtesy of the companies] Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in …
FDA approves next-gen drug delivery system from Medtronic
Oct 10, 2023 · The SynchroMed III system. [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity.
FDA clears iPhone app for the Insulet Omnipod 5 - Drug Delivery …
Oct 23, 2023 · Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet] Insulet (Nasdaq:PODD) announced today that the FDA granted 510(k) clearance for its Omnipod 5 App for iPhone. Clearance makes Insulet the only company offering a tubeless, automated insulin delivery (AID) system with full control from a compatible Android and iOS smartphone.
The company behind Narcan looks toward a treatment for fentanyl ...
Mar 13, 2018 · Ridiculous waste of resources. In South Florida there are now Narcan parties where the kids take turns resuscitating each other, sometimes a couple of times a night, since it’s now available over the counter in pharmacies, and then call 911 if they misjudge the timing, at a huge cost in time and resources of first responders.
CeQur acquires wearable insulin delivery device
Jul 17, 2018 · CeQur said today that it acquired a wearable, on-demand insulin delivery system from Johnson & Johnson‘s (NYSE:JNJ) Calibra Medical for an undisclosed amount.. The Calibra device is designed to dose rapid-acting, mealtime insulin for people with Type II diabetes. In a 278-person study, use of the Calibra device resulted in higher ease-of-use and patient satisfaction scores, as well as less ...